Grimes & Company »

Adma Biologics shares owned by Grimes & Company

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Grimes & Company from 13F filings

Historical chart of Grimes & Company investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Grimes & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Grimes & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $299k 45k 6.60
2023-12-31 $205k 45k 4.52
2023-09-30 $162k 45k 3.58
2023-06-30 $167k 45k 3.69
2023-03-31 $150k 45k 3.31
2022-12-31 $207k 53k 3.88
2022-09-30 $130k 53k 2.44
2022-06-30 $106k 53k 1.99
2022-03-31 $98k 53k 1.84
2021-12-31 $76k 54k 1.40
2021-09-30 $61k 54k 1.13
2021-06-30 $87k 54k 1.61
2021-03-31 $90k 51k 1.76
2020-12-31 $69k 35k 1.95
2020-09-30 $80k 34k 2.39